Can weight loss drugs lower your sex drive?
Some users report lower desire: 16% in one survey, versus 18% reporting higher desire, but the drugs have not been shown to cause these changes.
The Men’s Health article explores Low Libido and sexual changes among people using GLP-1 Medications, a group of drugs used for weight loss. It brings together survey results, other studies, and expert views.
A 2025 Kinsey Institute survey found mixed experiences among users. More than half said the medication affected their sex lives. Beyond changes in desire, 16% reported better sexual function; 12% reported worse function. Men were about twice as likely as women to report changes, whether positive or negative.
Other findings were less clear. A small study of dulaglutide, one drug in this group, found no change in desire after four weeks. Longer use was linked to slightly lower risk of moderate to severe Erectile Dysfunction, meaning trouble getting or keeping an erection. However, that study had drug-company funding. Larger studies without that funding are still needed.
One theory involves the brain’s reward system, which shapes what feels appealing. Animal studies suggest these drugs can change reward-related behavior. But animal doses and delivery methods often differ from human use. Those findings cannot tell us how people’s sexual desire changes.
Reports of change are not proof of cause. For BioSocial members, a dated symptom log could make comparisons more useful. Recording desire on the same scale each week can show personal patterns. Notes about when medication started can add context. Community comparisons can capture improvement, worsening, or no change—not just one expected outcome.
If you’ve used these medications, how has your desire changed over time?


Comments
No comments yet.